N/A N=25 Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA
Prostate Cancer
Primary: Prostate Cancer Detection Within the Prostate Gland by Copper Cu 64 TP3805 PET — 25 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=15 Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects
Metabolic Evaluation · Cardiac Complications
Primary: Assessing the Effect of ALA on the Blood Parameters: Lipid and Carbohydrate Framework — 180.60; 37.60; 88.80; 132 mg/dl
N/A N=190 Comparison of Ultrasonic Osteotome and Conventional Drill Osteotome
Arthrodesis
Primary: Number of Participants With Bone Fusion — 43; 60 Participants
N/A N=74 The Artificial Pancreas in Very Young Children With T1D
Type 1 Diabetes Mellitus
Primary: Time in Target (3.9 to 10.0 mmol/l) (70 to 180 mg/dl) — 71.6; 62.9 Percent of time spent in target range — p=<0.001
N/A N=175 THRIVE Use in Pediatric Populations- Multi Site
Oxygen Deficiency · Desaturation of Blood · Hypoventilation
Primary: Number of Participants With 4% Decrease From Baseline in Oxygen Desaturation Index — 18; 11; 13; 9 Participants — p=0.18
N/A N=201 Fit 5 Kids Screen Time Reduction Curriculum for Latino Preschoolers
Obesity, Childhood · Physical Activity · Nutrition
Primary: Screen Time — 122.6; 123.47; 97.3; 129.34 minutes/day — p=<0.05
Phase 4 N=25 Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting
Large B-cell Lymphoma · Diffuse Large B-cell Lymphoma
Primary: Number of Participants That Received YESCARTA — 20 Participants
Phase 3 N=199 Asciminib Treatment Optimization in ≥ 3rd Line CML-CP
Chronic Myelogenous Leukemia
Primary: Major Molecular Response (MMR) Rate at Week 48 for All Patients With no Evidence of MMR at Baseline — 42.35; 34.52 Percentage of responders
N/A N=104 Spontaneous Void Requirements for Patients Undergoing Ambulatory Anorectal Surgery
Complications, Postoperative
Primary: PACU Time — 129.1; 210.0 Minutes
N/A N=140 Opioid Consumption and Disposal After Shoulder Arthroplasty
Opioid Use
Primary: Difference in Proportion of Participants With > 10 Pills Left Unused. — 49; 47 Participants
N/A N=184 Intervention to Promote Survivor Resilience and Adjustment: Efficacy and Sustainability
Traumatic Brain Injury
Primary: Number of Subjects Completing the Two Structured Outpatient Intervention Programs Resilience and Adjustment Intervention (RAI) vs. RAI With Follow-up Booster Sessions…
N/A N=410 MyMenoPlan: Online Resource for Improving Women's Menopause Knowledge and Informed Decision-making
Menopause · Premenopause · Postmenopause
Primary: Perceived Quality of Information — 4.1; 3.7 score on a scale — p=<.001
N/A N=208 Neural Correlates of the Shift in Social Buffering of Social Evaluative Threat
Social Stress · Adolescent Behavior
Primary: Change in Cortisol AUCi — -0.04; 0.02; -0.01 (ug/dl)*minutes
N/A N=104 Does Switching to Nicotine Containing Electronic Cigarettes Reduce Health Risk Markers
Tobacco Dependence
Primary: Urinary NNAL Concentration — 151.6; 338.2 ng/ml — p=0.0039
N/A N=214 Happy Family, Healthy Kids Program
Healthy Diet · Stress · Pediatric Obesity
Primary: Child Dietary Fruit and Vegetable Intake — 0.07 Cups per day